Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 5 May 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 5 May 2026Mint
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Sensex dives 850 pts, Nifty slips below 24,200 amid oil shock and weak global cues
The equity benchmark indices Sensex and Nifty tumbled on Thursday, extending losses for a second straight session. Firm crude oil prices and ongoing geopolitical tensions rattled sentiment. Brent crude surged for the fourth consecutive day to around $103 per barrel amid uncertainty over US-Iran talks and fresh concerns around the Strait of Hormuz. Weak Asian cues and persistent foreign fund outflows deepened the sell-off. The Nifty slipped below the 24,200 mark, dragged by auto, PSU banks and consumer durables stocks, while pharma and healthcare shares saw selective buying. Investors stayed cautious, closely tracking the ongoing Q4 earnings season for further triggers.
CLSA says Nifty has given a new signal on the charts; check potential returns and top midcap 'buys'
Laurence Balanco of CLSA has shared five midcap ideas: BSE, MCX, Apollo Tubes, Dixon Technologies and Aurobindo Pharma.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade
Buy Dr Agarwals Health Care; target of Rs 610: Motilal Oswal
Motilal Oswal is bullish on Dr Agarwals Health Care recommended buy rating on the stock with a target price of Rs 610 in its research report dated Jun 05, 2026.
HDFC Life buys Rs 153 crore Motilal Oswal Financial shares, promoter sells 4.5% stake in NRB Bearings
Motilal Oswal Healthcare Foundation, and Motilal Oswal Foundation were sellers in Motilal Oswal Financial Services shares.
Stocks to Watch Today: NLC India, IRB Infrastructure, Rail Vikas Nigam, JNK India, Bharti Airtel, Vodafone Idea, NRB Bearings in focus on 09 June
Stocks to Watch, 09 June: Stocks like NLC India, IRB Infrastructure Developers, Panacea Biotec, Grasim Industries, HCL Technologies, Rail Vikas Nigam, JNK India, Motilal Oswal Financial Services, and NRB Bearings will be in focus on June 9.
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal
Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2610 in its research report dated June 01, 2026.
Buy Ipca Laboratories; target of Rs 1730: Motilal Oswal
Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 1730 in its research report dated June 01, 2026.
Buy Rubicon Research; target of Rs 1160: Motilal Oswal
Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 1160 in its research report dated May 30, 2026.
Neutral ALKEM Laboratories; target of Rs 5840: Motilal Oswal
Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5840 in its research report dated May 28, 2026.